Requirement of Dispensary (Pharmacist) in Dr B R Ambedkar National Institute of Technology
Dr B R Ambedkar National Institute of Technology was established in the year 1987 as Regional Engineering College and was given the status of National Institute of Technology (Deemed University) by the Government of India on October 17, 2002 under the aegis of Ministry of Human Resource Development, New Delhi. Now the Ministry of Human Resource Development, Government of India has declared the Institute as “Institute of National Importance” under the act of Parliament-2007. The Institute has been placed amongst top 50 engineering institutions of the country as per the survey conducted by Mint-C Fore in the year 2008. The survey was based upon vital parameters, such as curriculum, quality of academic input, students’ care, admission procedure, infrastructure, placements and overall goodwill of the Institute. A large number of reputed Industrial houses in the country visit the Institution and select the final year students as Engineers/ Management Trainees. The highest pay package offered to the B Tech students (Batch 2005-2009) has been Rs 7.2 lakhs per annum by M/S NTPC Delhi.
Subject: Requirement of Pharmacist on Contract Basis.
Post: Dispensary(Pharmacist)
[adsense:336x280:8701650588]

Maharshi Dayanand University, ab initio established as Rohtak University, Rohtak, came into existence by an Act No. 25 of 1975 of the Haryana Legislative Assembly in 1976 with the objective to promote inter-disciplinary higher education and research in the fields of environmental, ecological and life sciences.

Fresenius Kabi Oncology Limited is a public listed company primarily operating in the field of Research & Development and manufacturing of world-class oncology drugs. The company strives to provide most advanced third generation chemotherapeutic drugs right from development to manufacturing & marketing across the globe. It is fast emerging as a leading player in oncology generics on the strength of its comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and active pharmaceutical ingredients (APIs).
